Recent advances on the development of plasmon-assisted biosensors for detection of C-reactive protein

• Published in: Journal of molecular structure 2021-12, Vol.1246, p.131178-131178, Article 131178
• Main Authors: Nagy-Simon, Timea, Hada, Alexandru-Milentie, Suarasan, Sorina, Potara, Monica
• Format: Article
• Language: English
• Subjects: C-reactive protein; colorimetric detection; LSPR; MEF; plasmonic nanoparticles; SERS
• ISSN: 0022-2860; 1872-8014
• DOI: 10.1016/j.molstruc.2021.131178

•The relevance of CRP level for diseases diagnosis is discussed•An overview on plasmonic nanoparticles-based assays for CRP detection is provided•Improvement of the sensitivity and specificity of the detection assays is highlighted•Newly designed POC assays for rapid real sample analysis are presented Human C-reactive protein (CRP), an early clinical indicator of infectious or inflammatory conditions has been recently identified as a key biomarker associated with the development of COVID-19. The rapid and accurate determination of CRP level in blood serum is an urgent need to predict timely the risk of disease worsening. The emergence of nanotechnological tools has provided an attractive perspective in designing portable bioanalytical assays with fast response time, high sensitivity and specificity, and multiplexing capability for accurate, on-site disease diagnosis and monitoring. Due to their versatile optical properties, plasmonic nanoparticles (PNPs) are appealing candidates for biosensing applications. This review summarizes the advances in the application of PNPs for CRP detection and quantification. Particularly, we review the improvements attained in the detection of CRP using aggregation-based colorimetric, localized surface plasmon resonance (LSPR), plasmon-assisted fluorescence and chemiluminescence, and surface-enhanced Raman scattering (SERS) spectroscopic methods. [Display omitted]